Immersion Course on Comprehensive Lung Cancer Treatment and Surgical Innovation

Course Overview

Sponsored by the Division of Thoracic and Cardiac Surgery at Brigham and Women’s Hospital and featuring faculty from Harvard Medical School, this course offers a multidisciplinary perspective on the latest advancements in lung cancer care.

Designed for thoracic surgeons, oncologists, pulmonologists, radiologists, pathologists, and trainees, the program integrates live surgical demonstrations, hands-on workshops, didactic sessions, and case-based panel discussions. Topics range from early diagnosis and staging to advanced surgical techniques, molecular testing, immunotherapy, and multimodal treatment strategies.

The course emphasizes a comprehensive approach to lung cancer management, addressing the unique challenges of integrating surgery, systemic therapy, and radiation in a multidisciplinary care model. Sessions also highlight innovations in technology, including robotic and minimally invasive surgical techniques, along with insights into real-world applications, and cutting-edge research.

Participants at all stages of their careers will benefit from exposure to world-renowned faculty and the opportunity to engage in collaborative discussions, ensuring they leave equipped with the knowledge and tools to optimize patient outcomes in lung cancer care. 

Who Should Attend

• Specialty Physicians 

Learning Objectives

Upon completion of this activity, participants will be able to: 

• Describe the advantages and technical considerations associated with the minimally invasive strategies in the management of basic and complex thoracic disorders.
• Identify the factors leading to complications in minimally invasive robotic thoracic surgery for patients with lung cancer.
• Identify the factors leading to complications in minimally invasive uniportal VATS for patients with lung cancer.
• Explain the process by which technically advanced procedures may be incorporated into surgical practice.